Skip to content
NAFLD Prevalence Increasing in Pediatric Patients episode artwork

Apr 26, 2022 9 min

NAFLD Prevalence Increasing in Pediatric Patients

from HCPLive Podcasts Hosted by HCPLive.com

Last week, a new investigation confirmed a higher prevalence of non-alcoholic fatty liver disease (NAFLD) in pediatric patients than previously thought. The data was part of the ongoing observational study called TARGET-NASH, which included participants with NAFLD and/or alcoholic steatohepatitis (NASH). The study, which included 660 pediatric patients, cited an increase in liver disease following evaluation of alanine aminotransferase. Notably, pediatric patients with greater than 250 U/L ATL had an eight-fold greater risk of developing cirrhosis. For this episode of DocTalk, Miriam Vos, MD, MSPH, Department of Pediatrics, School of Medicine, Emory University, sat down with assistant managing editor Kenny Walter to discuss the data from TARGET-NASH as well as the implications of NAFLD in pediatric patients.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

NAFLD Prevalence Increasing in Pediatric Patients

0:00 9:03

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of HCPLive Podcasts?

This episode is 9 minutes long.

When was this HCPLive Podcasts episode published?

This episode was published on April 26, 2022.

Can I download this HCPLive Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.